Pankaj Deore’s Post

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of #3Dprinting in pharma, in conversation with Pharma‘s Almanac to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where Thomas Kipping, Ph.D., Head of 3D Printing and Solubility Enhancement, sheds light on the evolution, current state, and future prospects of 3D printing in pharma, in conversation with Pharma’s Almanac's to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment

Discover this Q&A, where we discuss the evolution, the current state, and future prospects of 3D printing in pharma, in conversation with Pharma's Almanac’s to discuss the topic of additive manufacturing, commonly known as 3D printing, and how it is reshaping pharmaceutical manufacturing. Big thank you at David Alvaro for the great discussion. 💡 💡 💡 Unlike traditional oral solid dose (OSD) manufacturing, 3D printing offers unparalleled flexibility in designing drug prototypes, final dosage forms enabling precision dosing and the creation of complex release kinetics. This technology is especially valuable during early R&D, for creating innovative dosage forms and streamlining the supply of clinical trial material. Our raw materials portfolio plays a leading role in the 3D printing space, establishing collaborations and developing products to realize the potential of additive manufacturing. #solidformulation #formulation #osd #drugdevelopment #3Dprinting

🔍 30 Days of Insights: Day 5 🔍 Additive manufacturing, also known as 3D printing, is poised to finally make personalized dosing a reality. Curious about what 3D printing is, and how it is revolutionizing pharmaceutical manufacturing? Read our recent article on the subject, and make sure to follow Pharma's Almanac as we take you across the life sciences industry with 30 Days of Insights: #biomanufacturing #pharmaceuticalindustry #healthcare #additivemanufacturing #3dprinting

Innovating the Future of Pharmaceuticals: A New Chapter in 3D Printing and AI Excited to unveil our latest milestone in pharmaceutical innovation: a book chapter titled "3D Printing of Pharmaceutical Products Using AI Technology," published in a prestigious volume accessible here: https://lnkd.in/dP64K8pT. This chapter represents a significant advance in the field, blending AI with 3D Printing (Additive Manufacturing) to redefine what's possible in drug production and personalized medicine. We delve into how this cutting-edge integration overcomes traditional barriers in 3D printing, such as enhancing production speeds, enabling automation, and facilitating the creation of complex, custom-tailored drug formulas. Our collaborative effort sheds light on the untapped potential of AI and Machine Learning to revolutionize pharmaceutical manufacturing, offering a blueprint for future innovations that prioritize efficiency, precision, and patient-specific care. This work not only paves the way for individualized medication solutions but also sets a new standard for the industry, moving us towards a more personalized, patient-centric healthcare model. I have heartfelt gratitude to my co-authors, Anand Kumar S, Sneha Sharma, and Dr Rajkumar Velu, for their unwavering dedication and profound insights. We are proud to contribute to this transformative journey in healthcare technology. #3DPrinting #AIinPharma #AdditiveManufacturing #PharmaceuticalManufacturing #DigitalHealth #InnovationInHealthcare